Historique
Article de Périodique
Cocaine and other illicit drugs in the marine environment: Potential effects and future directions (2024)
Auteur(s) :
HAUSER-DAVIS, R. A. ;
WOSNICK, N. ;
BARCELLOS HOFF, R. ;
VIANNA, M. ;
MENDES SAGGIORO, E.
Année
2024
Page(s) :
art. 117064
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
INTERNATIONAL
Thésaurus mots-clés
COCAINE
;
ENVIRONNEMENT
;
CONTAMINATION
;
POLLUTION
;
PRODUIT ILLICITE
Résumé :
Cocaine and its primary metabolite, benzoylecgonine, have been recently detected in sharks, indicating a growing concern over marine drug pollution. The presence of this drug in marine fauna poses risks such as physiological stress, impaired growth, reproduction, and altered behaviors, potentially leading to biodiversity loss and disrupted ecological interactions. Biomagnification may further affect higher trophic levels, including humans. Addressing this issue requires continuous monitoring, studies on physiological effects, understanding contamination routes, and improving wastewater treatment. Additionally, stricter regulations on pharmaceutical disposal are necessary to mitigate the impacts of such pollutants on marine ecosystems and human health. [Author's abstract]
Highlights:
Marine drug pollution can affect biota behavior, ecosystem balance, and biodiversity.
A significant lack of research on illicit drug effects in marine wildlife is noted.
Illicit drug biomagnification poses potential human health and public safety risks.
Continuous monitoring, effect and contamination route assessments are required.
Wastewater treatment and stricter pharmaceutical disposal regulations are necessary.
Highlights:
Marine drug pollution can affect biota behavior, ecosystem balance, and biodiversity.
A significant lack of research on illicit drug effects in marine wildlife is noted.
Illicit drug biomagnification poses potential human health and public safety risks.
Continuous monitoring, effect and contamination route assessments are required.
Wastewater treatment and stricter pharmaceutical disposal regulations are necessary.
Affiliation :
Laboratorio de Avaliaçao e Promoçao da Saude Ambiental, Instituto Oswaldo Cruz, Fundaçao Oswaldo Cruz, Rio de Janeiro, Brazil